Get started
Author

Karen Anne Cadoo

Observed names: Cadoo, Karen, K A Cadoo, K. A. Cadoo, K. Cadoo, K.A. Cadoo, Karen A Cadoo, Karen A. Cadoo, Karen Cadoo
Observed institutions: University College Dublin, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering Cancer Center, Trinity College Dublin, Cornell University, Richmond University Medical Center, Beaumont Hospital, Mater Misericordiae University Hospital, Cancer Trials Ireland, St. James's Hospital, Weill Cornell Medicine
ORCID: 0000-0002-8384-7148
Observed ORCID: 0000-0002-8384-7148
OpenAlex ID: A5050336579
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
2018 · Alicia Latham, Preethi Srinivasan, et al. · Journal of Clinical Oncology · 618
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
2017 · Diana Mandelker, Liying Zhang, et al. · JAMA · 514
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
2019 · Panagiotis A Konstantinopoulos, William T Barry, et al. · The Lancet Oncology · 262
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
2018 · Maria I. Carlo, Semanti Mukherjee, et al. · JAMA Oncology · 189
PDF
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
2021 · Elise M. Fiala, Gowtham Jayakumaran, et al. · Nature Cancer · 172
PDF
Therapeutic Implications of Germline Testing in Patients With Advanced Cancers
2021 · Zsofia K. Stadler, Anna Maio, et al. · Journal of Clinical Oncology · 154
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
2018 · Tara E. Soumerai, Mark T.A. Donoghue, et al. · Clinical Cancer Research · 145
Cancer Susceptibility Mutations in Patients With Urothelial Malignancies
2019 · Maria I. Carlo, Vignesh Ravichandran, et al. · Journal of Clinical Oncology · 131
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases
2021 · Edaise M. da Silva, Daniel J. Fix, et al. · Modern Pathology · 124
PDF
Palbociclib: an evidence-based review of its potential in the treatment of breast cancer
2014 · Tiffany Traina, Karen Cadoo, et al. · Breast Cancer Targets and Therapy · 111
PDF
The context-specific role of germline pathogenicity in tumorigenesis
2021 · Preethi Srinivasan, Chaitanya Bandlamudi, et al. · Nature Genetics · 105
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer
2021 · Jada G. Hamilton, Heather Symecko, et al. · Genetics in Medicine · 76
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers
2020 · Harini Veeraraghavan, Claire F. Friedman, et al. · Scientific Reports · 71
PDF
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
2019 · Marina Stasenko, Irina Tunnage, et al. · Gynecologic Oncology · 71
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer
2018 · Patrick G. Morris, Selene Rota, et al. · Clinical Breast Cancer · 62
High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer
2022 · Charles W. Ashley, Pier Selenica, et al. · Clinical Cancer Research · 61
PDF
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
2019 · Jessica J. Tao, Nicholas A. Cangemi, et al. · Clinical Cancer Research · 60
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
2017 · Komal Jhaveri, Rui Wang, et al. · Breast Cancer Research · 60
PDF
Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review
2015 · G M O’Kane, K A Cadoo, et al. · Clinical Sarcoma Research · 56
PDF
Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma
2019 · Derman Basaran, Shaina Bruce, et al. · Gynecologic Oncology · 49
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
2022 · Sarah Ehmann, Dib Sassine, et al. · Gynecologic Oncology · 48
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer
2020 · Ying L. Liu, Pier Selenica, et al. · JCO Precision Oncology · 48
PDF
Toward automation of germline variant curation in clinical cancer genetics
2019 · Vignesh Ravichandran, Zarina Shameer, et al. · Genetics in Medicine · 48
PDF
Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes
2020 · Lea A. Moukarzel, Arnaud Da Cruz Paula, et al. · Modern Pathology · 47
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
2018 · Julia L. Boland, Qin Zhou, et al. · Gynecologic Oncology · 47
PDF
Works count: 223
Citation count: 4,407
H-index: 33
I10-index: 61
Year
Topic
Type